InvestorsHub Logo
Followers 0
Posts 83
Boards Moderated 0
Alias Born 11/25/2016

Re: None

Tuesday, 04/25/2017 7:39:36 PM

Tuesday, April 25, 2017 7:39:36 PM

Post# of 38634
Lyrica .....the patents appear to expire on Dec 30, 2018.....why not just file an ANDA?

You don't have to worry about the $20m and the drug being a generic sells itself literally.

I just think why improve the drug if you can't find a partner to fund the trials and then the NDA drug will need a strong sales force when you can get a few million a month as a generic.

Just a penny pitching thought....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y